Alere also paid 806,452 restricted shares from its common stock.
Florida-based Arriva Medical provides diabetes testing supplies to individuals in their homes and has revenues of approximately $21.5m for the six months ended 31 October 2011.
Alere’s new product development efforts focus on cardiology, infectious disease, oncology, toxicology and women’s health.
